Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to analyze in detail selected indicators of appetite regulation, metabolism, and iron balance in competitive rowers undergoing intense exercise. The project involves assessing dynamic hormonal and biochemical changes in the athletes' bodies, which will allow a better understanding of the body's adaptive mechanisms to prolonged physical strain.
Research group: the research will be conducted in a homogeneous group of professional rowers (N=30), all competitors qualified for the Polish Youth Rowing Team:
Rowing performance test: At the beginning and end of the training camp, participants will perform a test on a rowing ergometer (Concept II, USA). Each subject will have to cover a distance of 2000 m in the shortest possible time, which is the distance starting in rowing competitions. The results of both tests will be considered in the selection for the championship team; therefore, athletes will be well motivated to perform both tests with maximum effort.
Blood samples will be taken from the cubital vein at three-time points: before each ergometer test (after overnight fasting), directly after the test, and after a 1-hour recovery period.
The study aims to conduct a detailed analysis of selected indicators of appetite regulation, metabolism, inflammation, and iron balance in competitive rowers undergoing intense exercise. The project involves assessing dynamic hormonal and biochemical changes in the athletes' bodies, which will allow for a better understanding of the body's adaptive mechanisms to prolonged physical strain.
Research group: The research will be conducted in a homogeneous group of professional rowers (N=30), all competitors qualified for the Polish Youth. Rowing Team:
Rowing performance test: at the beginning and at the end of the training camp, participants will perform a test on a rowing ergometer (Concept II, USA), each subject will have to cover a distance of 2000 m in the shortest possible time, which is the distance starting in rowing competitions. The results of both tests will be considered in the selection for the championship team; therefore, athletes will be well motivated to perform both tests with maximum effort.
Blood samples will be taken from the cubital vein at three-time points: before each ergometer test (after overnight fasting), directly after the test, and after a 1-hour recovery period.
Measurement: All determined parameters will be measured with the available equipment in the biochemical laboratory of Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow Wlkp., using commercial assay kits. Measurements will be performed by the project contractors.
Polyethylene tubes (4.9 ml) containing dipotassium ethylenediaminetetraacetic acid (EDTAK2) anticoagulant will be used for the following tests:
(a) complete blood count (18 parameters) determined on the MYTHIC 18 hematology analyzer (Orphee Medical, Geneva, Switzerland). White blood cell indices: WBC (white blood cells), LYM (lymphocytes as a percentage), LYM (lymphocytes), MON (monocytes as a percentage), MON (monocytes), GRA (granulocytes as a percentage), GRA (granulocytes). Red blood cell indices: RBC (Red Blood Cells), HGB (Hemoglobin), HCT (Hematocrit), MCV (Mean Corpuscular Volume), MCH (Mean Corpuscular Hemoglobin), MCHC (Mean Corpuscular Hemoglobin Concentration), RDW (Red Blood cells Distribution Width). Platelet indices: PLT (Platelet), MPV (Mean Platelet Volume), PDW (Platelet Distribution Width), PCT (Thrombocrit) (b) gene expression.
Polyethylene clotting activator tubes (9 ml) will be centrifuged to separate the morphotic elements from the serum using a centrifuge (3000 rpm for 10 min). The serum will be pipetted into several Eppendorf tubes, which will then be frozen (temp. -80°C). All the following biochemical parameters will be determined from the extracted serum: using the ELISA method by the test manufacturer's instructions. The designations include the flowing parameters:
Analysis of leptin, ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), pancreatic polypeptide (PP) and cholecystokinin (CCK) levels will allow assessment of dynamic hormonal changes in rowers in relation to training intensity, energy availability and diet composition.
Biochemical and hormonal parameters
Stress and recovery hormones:
Neurotransmitters associated with fatigue resistance:
Sex hormones and metabolic balance:
ferroptosis parameters
The iron and Total Iron Binding Capacity (TIBC) levels will be determined using the colorimetric method on the SPECTROstar Nano reader. Unsaturated Iron Binding Capacity (UIBC) will be calculated from the formula: UIBC = TIBC-iron in serum)
Markers of energy metabolism:
Markers of muscle damage:
Markers of metabolic adaptation and recovery:
- fibroblast growth factor-21 (FGF-21) - , a protein, regulates metabolism and restoration of energy resources, allows assessment of the body's adaptation to intense exercise.
Using a portable analyzer system for measuring blood gas, electrolytes and metabolites (epoc®), using dedicated epoc® test cards. Measured parameters: Direct: pH, partial pressure of carbon dioxide (pCO2), partial pressure of oxygen (pO2), total plasma carbon dioxide (tCO2), sodium (Na+), potassium (K+), calcium (Ca++), chlorine (Cl-), hematocrit (Hct), glukose (glu), Lactic Acid (Lac), Crea, Urea, urea nitrogen (BUN). Calculated values: cHgb, bicarbonate level (cHCO3), cTCO2, excess base in extracellular fluid (BE ecf), BE(b), total blood saturation (cSO2), glomerular filtration rate (GFRmdr), GFRmdr-a, GFRckd, GFRckd-a, GFRswz, anion gap (AGAP), AGapK, BUN/Crea, Urea/Crea. It will be determined from capillary blood taken from the earlobe (90 µl). Lactic acid will be determined from capillary blood taken from the earlobe (10 µl). The determination will be performed with dedicated reagents, using a portable biochemical photometer Vario Photometer II (Diaglobal, Berlin, Germany).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Physical effort | Rowers will perform an intensive exercise test on a rowing ergometer (Concept II, USA), covering a distance of 2000 meters in the shortest time possible. The test on the rowing ergometer will be performed under the supervision of a physician. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physical effort | Other | The examined athletes will be subjected to an effort on a rowing ergometer, covering a designated distance in the shortest possible time. |
|
| Measure | Description | Time Frame |
|---|---|---|
| The Blood morphology | Using MYTHIC18 hematology analyzer (Cormay Diagnostics, Geneva, Switzerland). Qualitative and quantitative evaluation of morphological elements of blood (determination in venous blood). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Glycogen level. | Concentration of glycogen [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline Insulin level. | Concentration of insulin [μIU/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baselineCreatine kinase activity (CK) level. | Concetration of CK [ng/ml]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline interleukin-6 (Il-6) level. | Concentration of Il-6 [pg/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in fibroblast growth factor 21 (FGF-21) level. | Concentration of FGF-21 [pg/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Measure | Description | Time Frame |
|---|---|---|
| Antropometric characteristic - height | Prior to the exercise test, we measured the anthropometric parameters, including height (Seca 213 Hamburg, Deutschland) [cm] | Day 1 after overall fast |
| Antropometric characteristic - weight |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The Polish Youth Rowing Team
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anna Skarpańska-Stejborn, Professor | Poznań University of Physical Education, Faculty of Sport Sciences in Gorzów Wielkopolski, Poland; | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Poznań University of Physical Education | Poznan | 61-871 | Poland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007249 | Inflammation |
| D009422 | Nervous System Diseases |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D005082 | Physical Exertion |
| ID | Term |
|---|---|
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
| Changes from baseline in lactic acid (LA) level. | Concetration of LA [mmol/l]. Using a portable biochemical photometer Vario Photometer II (Diaglobal, Berlin, Germany) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Gene expression | Genes studied: LEP, GHRL, AGRP, GOT1 and GPX4. RNA isolation will be performed by the column method on the Direct-zol™ RNA MiniPrep Plus Kits, according to the test manufacturer's instructions. Gene expression analysis from cells isolated from blood will be performed by reverse transcription using TaqMan | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in testosterone level. | Concentration of testosterone [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in serotonin level. | Concentration of serotonin [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery |
| Changes from baseline in progesterone level. | Concentration of progesterone [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery |
| Changes from baseline in estradiol level. | Concentration of estradiol [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery |
| Changes from baseline in dopamine level. | Concentration of dopamine [ng/mL]. Immunoenzymatic assay method using a diagnostic ELISA Kit | At rest (before the exercise test), 1 minute after the end of the test, after 1 hour of recovery |
| Baseline Mood Profile of Athletes Before Exercise Test Using POMS Questionnaire. | The Profile of Mood States (POMS) questionnaire measures mood states and emotional well-being. | At rest (before the exercise test). |
| Baseline Mental Toughness in Sport measured using the Scale of Mental Toughness in Sport (SMTQ) | Scale of Mental Toughness in Sport (SMTQ) - to assess an athlete's ability to cope with training loads and stress | At rest (before the exercise test). |
| Baseline Eating Behavior and Attitudes of Athletes Before Exercise Test Using EDE-Q 6.0 Questionnaire. | The Eating Disorder Examination Questionnaire (EDE-Q) measures the severity of eating disorder behaviors and attitudes. | At rest (before the exercise test). |
| Baseline Appetite Assessment of Athletes Before Exercise Test Using Visual Analogue Scale (VAS). | The Visual Analogue Scale (VAS) measures subjective appetite sensations-linear scale from one to 10 where 10 is the strongest feeling. | At rest (before the exercise test). |
| Changes from baseline in leptin(LEP) level. | Satiety regulation marker. Concentration of leptin [pg/ml].ELISA method by the test manufacturer's instructions. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in glucagon-like peptide-1 (GLP-1) level. | Satiety regulation marker. Concentration of GLP-1 [pg/ml]. ELISA method by the test manufacturer's instructions. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in peptide YY (PYY) level. | Satiety regulation marker. Concentration of leptin [pg/ml]. ELISA method by the test manufacturer's instructions. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in pancreatic polipeptide (PP) level. | Satiety regulation marker. Concentration of PP [pg/ml]. ELISA method by the test manufacturer's instructions | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in ghrelin (GHRL) level. | Hunger regulation marker. Concentration of GHRL [pg/ml].ELISA method by the test manufacturer's instructions. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in cholocystokinin (CCK) level. | Satiety regulation marker. Concentration of CCK [pg/ml].ELISA method by the test manufacturer's instructions. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Soluble transferrin receptor level. | Concentration of Soluble transferrin receptor [μg/ml]. ELISA method by the test manufacturer's instructions. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Ferritin level. | Concentration of ferritin [ng/mL]. ELISA method by the test manufacturer's instructions | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in 4-Hydroxynonenal (4-HNE) level. | Concentration of 4-Hydroxynonenal (4-HNE) [pg/ml]. ELISA method by the test manufacturer's instructions | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Glutathione Peroxidase 4 (GPX4) level. | Concentration of Human Glutathione Peroxidase 4 (GPX4) [ng/mL]. ELISA method by the test manufacturer's instructions | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Glutathione level. | Concentration of Glutathione (GSH) [μg/mL]. ELISA method by the test manufacturer's instructions. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Heme Oxygenase 1(HO-1) level. | Concentration of Heme Oxygenase 1 (HO-1) [ng/mL]. ELISA method by the test manufacturer's instructions | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Erythroferrone level. | Concentration of erythroferrone [ng/mL]. ELISA method by the test manufacturer's instructions | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Lactoferrin level. | Concentration of lactoferrin [ng/mL]. ELISA method by the test manufacturer's instructions | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in Iron (Fe) level. | The iron level [µg/dL] will be determined using the colorimetric method on the SPECTROstar Nano reader. | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - urea nitrogen (BUN) level. | Concentration of BUN [ml/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - anion gap (AGAP) level. | Concentration of AGAP [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - excess base in extracellular fluid (BE ecf) level. | Concentration of Be ecf [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - sodium (Na) level. | Concentration of Na [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - calcium (Ca) level. | Concentration of Ca [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - potassium (K) level. | Concentration of K [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - chlorine (Cl) level. | Concentration of Cl [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - bicarbonate level (cHCO3). | Concentration of cHCO3 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - total plasma CO2 (tCO2) level. | Concentration of tCO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - partial pressure of carbon dioxide (pCO2) | Concentration of pCO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - partial pressure of oxygen (pO2) | Concentration of pO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance -total blood saturation (cSO2) level. | Concentration of cSO2 [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - urea level. | Concentration of urea [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - crea level. | Concentration of crea [mg/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - hematocrit [hct] level. | Concentration of hct [%]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - hemoglobin [chgb] level. | Concentration of chgb [mmol/l]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
| Changes from baseline in acid-base balance - glukose [glu] level. | Concentration of glu [mg/dl]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe). | At rest (before the test), directly after the test, and after a 1-hour recovery period. |
Prior to the exercise test, we measured the anthropometric parameters, including weight (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]
| Day 1 after overall fast |
| Antropometric characteristic - LBM | Prior to the exercise test, we measured the anthropometric parameters, including lean body mas (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg] | Day 1 after overall fast |
| Antropometric characteristic - TBW | Prior to the exercise test, we measured the anthropometric parameters, including total body water (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg] | Day 1 after overall fast |
| Antropometric characteristic - Water% | Prior to the exercise test, we measured the anthropometric parameters, including water (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [%] | Day 1 after overall fast |
| Antropometric characteristic - FAT | Prior to the exercise test, we measured the anthropometric parameters, including fat (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [%] | Day 1 after overall fast |
| Food record - energy | Participants will prepare a food record. The results will be calculated using the dietetykpro program: energy [kcal] | Day before the Day 1, in the morning at Day 1 |
| Food record - protein | Participants will prepare a food record. The results will be calculated using the dietetykpro program: protein [g] | Day before the Day 1, in the morning at Day 1 |
| Food record - carobhydrates | Participants will prepare a food record. The results will be calculated using the dietetykpro program: carbohydrates [g] | Day before the Day 1, in the morning at Day 1 |
| Food record - fiber | Participants will prepare a food record. The results will be calculated using the dietetykpro program: fiber [g] | Day before the Day 1, in the morning at Day 1 |
| Food record - fat | Participants will prepare a food record. The results will be calculated using the dietetykpro program: fat [g] | Day before the Day 1, in the morning at Day 1 |